A screening method for mild cognitive impairment in elderly individuals combining bioimpedance and MMSE

Min-Ho Jun1, Boncho Ku1,2, Kahye Kim1

  • 1Digital Health Research Division, Korea Institute of Oriental Medicine (KIOM), Daejeon, Republic of Korea.

PubMed

Insights

A new screening method combining bioimpedance and Korean Mini-Mental State Examination (K-MMSE) effectively identifies mild cognitive impairment (MCI) in older adults. This approach offers a faster, more accurate tool for early detection of cognitive decline.

Area of Science:

  • Gerontology
  • Neurology
  • Biomedical Engineering

Background:

  • Mild cognitive impairment (MCI) is a growing concern in aging populations.
  • Early detection of MCI is crucial for timely intervention and management.
  • Current screening methods may lack sufficient accuracy or accessibility.

Purpose of the Study:

  • To develop and validate a novel screening method for MCI.
  • To combine bioimpedance analysis with K-MMSE scores for improved diagnostic accuracy.
  • To compare the performance of the combined model against existing screening tools and machine learning approaches.

Main Methods:

  • A cohort of 539 elderly individuals (≥60 years) was recruited.
  • Data included bioimpedance measurements, K-MMSE scores, and Seoul Neuropsychological Screening Battery (SNSB-II) assessments.
  • A multiple linear regression model was developed using bioimpedance and K-MMSE data to predict MCI, with performance evaluated using Area Under the Receiver Operating Characteristic Curve (AUROC).

Main Results:

  • The combined bioimpedance-K-MMSE model achieved higher AUROC values (0.790 for males, 0.773 for females) compared to K-MMSE alone (0.723 males, 0.622 females) or bioimpedance alone (0.640 males, 0.615 females).
  • The model's accuracy was comparable to advanced machine learning models.
  • The combined model demonstrated significant improvement in distinguishing MCI participants.

Conclusions:

  • The integration of bioimpedance features with K-MMSE offers a promising, rapid, and accurate screening tool for MCI in the elderly.
  • This method can enhance early identification of individuals at risk for cognitive impairment.
  • Further validation in diverse populations is warranted to establish its clinical utility.

Related Concept Videos